Primary sclerosing cholangitis in two brothers: Report of a family with special emphasis on molecular HLA and MICA genotyping

European Journal of Gastroenterology and Hepatology

Volumn 17, Issue 7, 2005, Pages 767-771

  Van Steenbergen, Werner ^a   De Goede, Eric ^b   Emonds, Marie Paule ^a   Reinders, Judith ^c   Tilanus, Marcel ^c   Fevery, Johan ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b VIRGA JESSE HOSPITAL   (Belgium)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Bile duct diseases; Endoscopic retrograde cholangiopancreatography; HLA DQ antigens; HLA DR antigens; MICA; Sclerosing cholangitis

Indexed keywords

ALKALINE PHOSPHATASE; HLA ANTIGEN CLASS 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 A; MESALAZINE; NEUTROPHIL CYTOPLASMIC ANTIBODY; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ADOLESCENT; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ALLELE; CASE REPORT; CHOLESTASIS; COLON BIOPSY; COLONOSCOPY; DNA POLYMORPHISM; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GENETIC SUSCEPTIBILITY; GENOTYPE; HLA SYSTEM; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOGENETICS; LIVER BIOPSY; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; REVIEW; SCLEROSING CHOLANGITIS; SEROLOGY; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; ALLELES; CHOLANGITIS, SCLEROSING; FAMILY HEALTH; FEMALE; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SIBLINGS;

EID: 21244465922     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200507000-00013     Document Type: Review

References (55)

1. Angulo P, Undor KD, Primary sclerosing cholangitis. Hepatotogy 1999; 30:325-332.
2. Cullen S, Chapman R. Aetiopathogenesis of primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 2001; 15:577-589.
3. Quigley EM, LaRusso NF, Ludwig J, MacSween RN, Birnie GG, Watkinson G. Familial occurrence of primary sclerosing cholangitis and ulcerative colitis. Gastroentemlogy 1983; 85:1160-1165.
4. Jorge AD, Esley C, Ahumada J. Family incidence of primary sclerosing cholangitis associated with immunologie diseases. Endoscopy 1987; 19:114-117
5. Habior A, Rawa T, Orlowska J, Sankowska M, Lewartowska A, Tilszer A, et al. Association of primary sclerosing cholangitis, ulcerative colitis and coeliac disease in female siblings. Eur J Gastroenterol Hepatol 2002; 14:787-791.
6. Reinders J, Rozemuller EH, Ongkosuwito JV, Jager MJ, Tilanus MG, Suttorp-Schulten MS. MICA association with presumed ocular histoplasmosis syndrome (POHS). Mol Vis 2003; 9:420-424.
7. Rozemuller EH, Bouwens AG, Bast BE, Tilanus MG. Assignment of HLA-DPB alleles by computerized matching based upon sequence data. Hum Immunol 1993; 37:207-212.
8. Versluis LF, Rozemuller E, Tonks S, Marsh SG, Bouwens AG, Bodmer JG, et al. High resolution HLA-DPB typing based upon computerized analysis of data obtained by fluorescent sequencing of the amplified polymorphic exon 2. Hum Immunol 1993; 38:277-283.
9. Record CO, Shilkin KB, Eddleston ALWF, Williams R. Intrahepatic sclerosing cholangitis associated with a familial immunodeficiency syndrome. Lancet 1973; ii:18-20.
10. Waldram R, Tsantoulas D, Kopelman H, Williams R. Chronic pancreatitis, sclerosing cholangitis, and sicca complex in two siblings. Lancet 1975; i:550-552.
11. Silber GH, Finegold MJ, Wagner ML, Klish WJ. Sclerosing cholangitis and ulcerative colitis in a mother and her son. J Pediatr Gastroenterol Nutr 1987; 6:147-152.
12. Seibold F, Slametschka D, Gregor M, Weber P. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1994; 107:586-589.
13. Bergquist A, Lindberg G, Saarinen S, Broomé U. Increased prevalence of primary sclerosing cholangitis among first-degree relatives. J Hepatol 2005; 42:252-256.
14. Chapman RW, Varghese Z, Gaul R, Patel G, Kokinon N, Sherlock S. Association of primary sclerosing cholangitis with HLA-B8. Gut 1983; 24:38-41.
15. Schrumpf E, Fausa O, Ferre OØ, Dobloug JH, Ritland S, Thorsby E. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol 1982; 17:187-191.
16. Donaldson PT, Farrant JM, Wilkinson ML, Hayllar K, Portmann BC, Williams R. Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis. Hepatology 1991; 13:129-133.
17. Prochazka EJ, Terasaki PI, Park MS, Goldstein LI, Busuttil RW. Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med 1990; 322:1842-1844.
18. Noguchi K, Kobayashi M, Yagihashi A, Yoshida Y, TerasawaK, Konno A, et al. HLA antigens in primary sclerosing cholangitis. Transpl Proc 1992; 24:2775-2776.
19. Leidenius MH, Koskimies SA, Kellokempu IH, Hockerstedt KA. HLA antigens in ulcerative colitis and primary sclerosing cholangitis. APMIS 1995; 103:519-524.
20. Farrant JM, Doherty DG, Donaldson PT, Vaughan RW, Hayllar KM, Welsh KI, et al. Amino acid substitutions at position 38 of the DRβ polypeptide confer susceptibility to and protection from primary sclerosing cholangitis. Hepatology 1992; 16:390-395.
21. Park MS, Terasaki PI. Inability to attribute susceptibility to primary sclerosing cholangitis to specific amino acid positions of the HLA-DRw52a allele. N Engl J Med 1991; 325:1252.
22. Boberg KM, Lundin KEA, Schrumpf E. Etiology and pathogenesis in primary sclerosing cholangitis. Scand J Gastroenterol 1994; 29 (suppl 204): 47-58.
23. Spurkland A, Saarinen S, Boberg KM, Mitchell S, Broome U, Caballeria L, et al. HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens 1999; 53:459-469.
24. Olerup O, Olsson R, Hultcranz R, Broome U. HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing choiangitis. Gastroenterology 1995; 108:870-878.
25. Donaldson PT, Norris S. Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis. Autoimmunity 2002; 35:555-564.
26. Donaldson PT, Norris S. Immunogenetics in PSC. Best Pract Res Clin Gastroenterol 2001; 15:611-627.
27. Stokkers PC, Reitsma PH, Tytgat GN, van Deventer SJ. HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut 1999; 45:395-401.
28. Saarinen S, Olerup O, Broomé U. Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis. Am J Gastroenterol 2000; 95:3024-3026.
29. Wiesner RH, Porayko MK, LaRusso NF, Ludwig J. Primary sclerosing cholangitis. In: Schiff L, Schiff ER, editors. Diseases of the Liver, 7th ed., vol. 1. Philadelphia: JB Lippincott Company; 1993. pp. 411-426.
30. Czaja AJ, Santrach PJ, Moore SB. Shared genetic risk factors in autoimmune liver disease. Dig Dis Sci 2001; 46:140-147.
31. Doherty DG, Donaldson PT, Underhill JA, Farrant JM, Duthie A, Mieli-Vergani G, et al. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology 1994; 19:609-615.
32. Strettell MDJ, Donaldson PT, Thomson LJ, Santrach PJ, Moore SB, Czaja AJ, et al. Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology 1997; 112:2028-2035.
33. Godkin A, Jewell D. The pathogenesis of celiac disease. Gastroenterology 1998; 115:206-210.
34. Louka AS, Sollid LM. HLA in celiac disease: unravelling the complex genetics of & complex disorder. Tissue Antigens 2003; 61:105-117.
35. Reveille JD, Arnett FC. The immunogenetics of Sjögren's syndrome. Rheum Dis Clin North Am 1992; 18:539-550.
36. Loiseau P, Lepage V, Djelal F, Busson M, Tamouza R, Raffoux C, et al. HLA class I and class II are both associated with the genetic predisposition to primary Sjögren syndrome. Hum Immunol 2001; 62:725-731.
37. Bilbao JR, Martin-Pagola A, Perez de Nanclares G, Calvo B, Vitoria JC, Vazquez F, et al. HLA-DRB1 and MICA in autoimmunity. Common associated alleles in autoimmune disorders. Ann NY Acad Sci 2003; 1005:314-318.
38. Noble JA, Valdes AM, Cook M, Klitz W, Thomson G, Erlich HA. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 1996; 59:1134-1148.
39. Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok CC, et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 1999; 167:257-274.
40. Van Steenbergen W, Fevery J, Vandenbrande P, Desmet V, Ponette E, Kerremans R, et al. Ulcerative colitis, primary sclerosing cholangitis, bile duct carcinoma, and generalized sarcoidosis. Report of a unique association. J Clin Gastroenterol 1987; 9:574-579.
41. Keller K, Hofmann WJ, Kayser K, Limberg B, Lippert J, Werner A, et al. Coincidence of primary sclerosing cholangitis and sarcoidosis - case report and review of the literature. Z Gastroenterol 1997; 35:33-39.
42. Lidar M, Langevitz P, Livneh A, Weiss P, Yosepovich A. Sclerosing cholangitis associated with systemic sarcoidosis. J Clin Gastroenterol 2003; 36:84-85.
43. Martinetti M, Tinelli C, Kolek V, Cuccia M, Salvaneschi L, Pasturenzi L, et al. "The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med 1995; 152:557-564.
44. Sato H, Grutiers JC, Pantelidis P, Mizzon AN, Ahmad T, van Houte A-J, et al. HLA-DQB1*0201. A marker for good prognosis in British and Dutch patients with sarcoidosis. Am J Respir Cell Mol Biol 2002; 27: 406-412.
45. Bogunia-Kubik K, Tomeczko J, Suchnicki K, Lange A. HLA-DRB*03, HLA-DRB*11 or HLA-DRB*12 and their respective DRB3 specificities in clinical variants in sarcoidosis. Tissue Antigens 2001; 57:87-90.
46. Bernal W, Moloney M, Underhill J, Donaldson PT. Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis. J Hepatol 1999; 30:237-241.
47. Mitchell SA, Grove J, Spurkland A, Boberg KM, Fleming KA, Day CP, et al. Association of the tumour necrosis factor alpha-308 but not the interleukin 10-627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis. Gut 2001; 49:288-294.
48. Norris S, Kondeatis E, Collins R, Satsangi J, Clare M, Chapman R, et al. Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism. Gastroenterology 2001; 120:1475-1482.
49. Wiencke K, Spurkland A, Schrumpf E, Boberg KM. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles. Hepatology 2001; 34:625-630.
50. Stephens HAF. MICA and MICB genes: can the enigma of their polymorphism be resolved? Trends Immunol 2001; 22:378-385.
51. Pardoll DM. Stress, NK receptors, and immune surveillance. Science 2001; 294:534-536.
52. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducable MICA. Science 1999; 285:727-729.
53. Diefenbach A, Raulet DH. Natural killer cells: stress out, turn on, tune in. Curr Biol 1999; 9:R851-R853.
54. Cerwenka A, Lanier LL. NKG2D ligands: unconventional MHC class I-like molecules exploited by viruses and cancer. Tissue Antigens 2003; 61:335-343.
55. Martins EBG, Graham AK, Chapman RW, Fleming KA. Elevation of γδ T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune diseases. Hepatology 1996; 23:988-993.